Traditional Chinese medicine composition for treating gastroesophageal reflux cough and pharmaceutical preparation and application thereof

Through traditional Chinese medicine compositions composed of drugs such as Coptis chinensis and Everrucidum, it clears the liver and relieves heat, lowers qi and relieves cough, and regulates gastroesophageal reflux cough, which solves the treatment problems in the existing technology, and achieves efficient symptom improvement and safe therapeutic effects. It is significant. Better than Western medicine treatment effect.

CN118987154APending Publication Date: 2024-11-22YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411157099.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

There is a lack of effective treatment plans for gastroesophageal reflux cough in the prior art, especially treatment difficulties caused by nerve reflexes. In addition, pure acid-suppressing drugs in Western medicine cannot relieve cough symptoms, and traditional Chinese medicine has fewer applications in this regard.

Method used

Using traditional Chinese medicine compositions composed of drugs such as Coptis chinensis, Everrucidae, Syringo-suppressing stalk, Ozhe, Fritillaria, etc., it is prepared into a drug preparation or health food by clearing the liver and relieving heat, reducing qi and relieving cough, and regulating the lung and gastric qi mechanism. Prevent or treat gastroesophageal reflux cough.

Benefits of technology

It significantly improves the symptoms and cough related to gastroesophageal reflux disease, has better clinical efficacy than Western medicine, has a recovery treatment rate of 65%, and has a total effective efficiency of 90%, with few side effects and is not prone to recurrence.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005005311600000061
    Figure BDA0005005311600000061
  • Figure BDA0005005311600000072
    Figure BDA0005005311600000072
  • Figure BDA0005005311600000073
    Figure BDA0005005311600000073
Patent Text Reader

Abstract

The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating gastroesophageal reflux cough and a pharmaceutical preparation and application thereof. The traditional Chinese medicine composition is prepared from, by weight, 3-6 parts of rhizoma coptidis, 3-6 parts of fructus evodiae, 10-20 parts of inula pedunculata, 15-25 parts of ruddle, 10-20 parts of fructus aurantii, 10-20 parts of rhizoma pinelliae, 5-10 parts of pericarpium citri reticulatae, 3-6 parts of fresh ginger, 10-20 parts of radix glehniae, 10-20 parts of radix scutellariae, 10-20 parts of bulbus fritillariae thunbergii and 20-30 parts of concha meretricis seu cyclinae. Pharmacodynamic experiments prove that the traditional Chinese medicine composition formula provided by the invention can effectively inhibit reflux, reduce the occurrence of airway neurogenic inflammation, improve respiratory tract inflammatory response and achieve the purpose of treating gastroesophageal reflux cough, the clinical effect is affirmative, no obvious adverse reaction is found, and the traditional Chinese medicine composition has a remarkable new medicine transformation application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of Chinese medicine compositions, and in particular to a Chinese medicine composition for treating gastroesophageal reflux cough, and a pharmaceutical preparation and application thereof. Background Art

[0002] Gastroesophageal Reflux Cough (GERC) is a special type of gastroesophageal reflux disease, with chronic cough as the main manifestation. Chronic cough recurs frequently, often resulting in a significant decline in the patient's quality of life. Related studies have shown that more than half of gastroesophageal reflux cough (GERC) only presents as repeated, difficult-to-heal coughs, lacking symptoms of gastroesophageal reflux disease, and is easily confused with respiratory and throat diseases. GERC caused by nerve reflexes is more difficult to find a breakthrough in treatment than gastroesophageal reflux disease, and there is still no optimal treatment plan.

[0003] According to TCM theory, gastroesophageal reflux cough (GERC) belongs to the category of "internal injury cough" in TCM. TCM has laid a deep theoretical foundation for the discussion of cough. For example, the "Inner Canon of Medicine" says "all the internal organs can cause cough, not just the lungs" and "these are all gathered in the stomach and related to the lungs", which provide a solid basis for the lung-stomach related theory. The lung and stomach are close to each other and connected by meridians. The lung belongs to metal and the stomach belongs to earth. The two can be said to be the mother and child organs. They are physiologically interdependent and complementary. Any pathogenic factors that cause the stomach to lose harmony and descend can affect the lung's descending, leading to the upward reversal of lung qi and cough. Coughing from the stomach is bound to affect the qi mechanism of the middle jiao first, and the qi mechanism of the middle jiao is closely related to the liver. Therefore, GERC mainly involves the lungs, stomach, and liver. The pathological basis of GERC lies in the disorder of qi movement. The basic pathogenesis is liver failure to dredge, stomach failure to harmonize and descend, and lung failure to descend. However, there is no better solution for the Chinese medicine composition for treating gastroesophageal reflux cough (GERC) using the above-mentioned etiology and pathogenesis in the prior art.

[0004] At present, Western medicine still mainly treats GERC with simple acid-suppressing drugs, which cannot relieve the symptoms of cough. Traditional Chinese medicine has certain advantages in treating GERC. It can relieve gastroesophageal reflux symptoms such as heartburn and acid reflux, as well as lung symptoms such as choking and coughing through multiple pathways and targets, and has the characteristics of few side effects and high safety. Summary of the invention

[0005] The present invention aims to provide a Chinese medicine composition and a pharmaceutical preparation for treating gastroesophageal reflux cough with small side effects and low recurrence, as well as the use of the Chinese medicine composition or the pharmaceutical preparation in preparing medicines or health foods for preventing or treating gastroesophageal reflux cough.

[0006] The inventors have found in long-term clinical practice that the Chinese medicine composition composed of drugs such as coptis root, evodia rutaecarpa, scutellaria baicalensis, daizheshi, thunbergia thunbergii, and sea clam shells focuses on clearing the liver and relieving heat, descending qi and relieving cough, and can significantly improve gastroesophageal reflux disease-related symptoms and lung symptoms such as cough. It has good clinical efficacy in treating gastroesophageal reflux cough.

[0007] The first aspect of the present invention provides a Chinese medicine composition for preventing or treating gastroesophageal reflux cough, wherein the Chinese medicine composition is composed of the following raw materials in parts by weight:

[0008] 3-6 parts of Coptis chinensis, 3-6 parts of Evodia rutaecarpa, 10-20 parts of Inula rhizome, 15-25 parts of magnetite, 10-20 parts of Fructus Aurantii Immaturus, 10-20 parts of Pinellia ternata, 5-10 parts of Pericarpium Citri Reticulatae, 3-6 parts of Ginger, 10-20 parts of Adenophora Root, 10-20 parts of Scutellaria baicalensis, 10-20 parts of Fritillaria thunbergii, and 20-30 parts of Clam Shells.

[0009] Further, the preferred traditional Chinese medicine composition of the present invention is composed of the following raw materials in parts by weight: 3 parts of coptis chinensis, 3 parts of evodia rutaecarpa, 12 parts of inula stem, 15 parts of magnetite, 12 parts of fructus aurantii, 12 parts of pinellia, 6 parts of tangerine peel, 3 parts of ginger, 15 parts of adenophora adenophora, 15 parts of scutellaria baicalensis, 12 parts of fritillaria thunbergii, and 30 parts of sea clam shells.

[0010] In the traditional Chinese medicine composition, coptis root and evodia rutaecarpa are the main drugs, inula stem, magnetite and aurantium are the assistant drugs, pinellia tuber, tangerine peel and ginger are the adjuvant drugs, and adenophora adenophora, scutellaria baicalensis, fritillaria thunbergii and sea clam shell are the guiding drugs.

[0011] The second aspect of the present invention provides a pharmaceutical preparation having the above-mentioned Chinese medicine composition for preventing or treating gastroesophageal reflux cough as an active ingredient. The pharmaceutical preparation is prepared into a commonly used dosage form in pharmacy by conventional preparation methods in the art.

[0012] Furthermore, the pharmaceutical preparation of the present invention can be prepared by the following method:

[0013] As a preferred technical solution, the preparation method of the Chinese medicine composition is as follows: take the raw materials according to the weight portion described in any of the above embodiments, mix them according to the proportion, add 8 times the total amount of water of the medicinal materials, heat and boil for half an hour, and pour out the decoction. Add 6 times the total amount of water of the medicinal materials again, heat and boil for half an hour, pour out the decoction, combine the decoctions, filter, and combine the medicinal liquids.

[0014] The third aspect of the present invention provides the use of the above-mentioned Chinese medicine composition and pharmaceutical preparation in the preparation of medicines or health foods for preventing or treating gastroesophageal reflux cough.

[0015] The dosage of the present invention is a therapeutically effective amount, for example, about 2 g / kg body weight to about 3 g / kg body weight per day. The general medication period is 2-12 months, preferably 2-6 months. Of course, the medication period also needs to consider the route of administration and the patient's health status, which are all within the skill range of skilled physicians.

[0016] In addition, the Chinese medicine composition of the present invention can be used as the sole active ingredient to prevent or treat gastroesophageal reflux cough, and can also be used together with other therapeutic agents, such as proton pump inhibitors or vonoprazan.

[0017] There is no related disease name for GERC in traditional Chinese medicine. According to its clinical symptoms, it can be diagnosed as "stomach cough". GERC is located in the lungs and stomach, with the stomach as the root and the lungs as the target, and the pathological mechanism is complex.

[0018] This prescription uses Coptis chinensis and Evodia rutaecarpa as the main drugs to relieve liver and clear heat, Inula fructus, Radix Daiheshi and Fructus Aurantii Immaturus as the assistant drugs to descend qi and harmonize the stomach, Pinellia ternata, Citrus reticulata and ginger as the adjuvant drugs to harmonize the stomach, Adenophora scutellariae, Baicalinium scutellariae, Fritillaria thunbergii and Sea clam shell as the guiding drugs to clear heat and relieve cough.

[0019] The properties, flavors, meridians and functions of the various drugs in the prescription of the present invention, as well as their commonly used weights are as follows:

[0020] Coptis chinensis: Also known as Weilian, Chuanlian, Jizhaolian, it is a perennial herb belonging to the Ranunculaceae family and the genus Coptis. It tastes bitter and is cold in nature. It enters the heart meridian, stomach meridian, liver meridian, and large intestine meridian. Efficacy: clearing away heat and dampness, purging fire and detoxifying. Indications: gastrointestinal damp-heat, vomiting, diarrhea, high fever and coma, restlessness and insomnia, vomiting and bleeding due to blood heat, sores and swelling, purulent ears, wet sores, and toothache due to stomach fire.

[0021] Evodia rutaecarpa: It is hot in nature, bitter and pungent in taste, and has the functions of dispelling cold and relieving pain, relieving adverse effects and stopping vomiting. It is used to treat headaches or epigastric pain caused by liver and stomach deficiency and cold, and upward flow of yin turbidity.

[0022] Inula stem: the flower head of Inula Japonica Thunb. or I. britannica, a herbaceous plant of the Asteraceae family. Nature and flavor and meridians: bitter, pungent, salty, slightly warm. Enters the lung, spleen, and large intestine meridians. Efficacy: descends qi to stop vomiting, resolves phlegm and stops coughing. Indications: belching, vomiting, wheezing, coughing, and excessive sputum.

[0023] Daizheshi: bitter, sweet, slightly cold. Enters the liver, stomach, and heart meridians. Indications: soothes the liver and suppresses yang, calms the stomach and suppresses adverse reactions, cools blood and stops bleeding, and is used to treat headaches, dizziness, palpitations, madness, epilepsy, vomiting, belching, hiccups, choking, coughing, asthma, hematemesis, epistaxis, metrorrhagia, blood in the stool, and blood in the urine.

[0024] Citrus aurantium: bitter, pungent, sour, warm, efficacy: breaking qi, removing phlegm, eliminating accumulation. Indications: chest phlegm stagnation, chest fullness, flank distension, food accumulation, belching, vomiting, heaviness after diarrhea, rectal prolapse, uterine prolapse.

[0025] French Pinellia: It is the tuber of the plant Pinellia of the Araceae family. Take clean Pinellia, separate the big and small, soak in water until there is no dry core inside, and take it out; take an appropriate amount of licorice, add water and boil twice, combine the decoction, pour into the lime solution made with an appropriate amount of water, stir well, add the soaked Pinellia mentioned above, soak, stir 1 to 2 times a day, and keep the pH value of the soaking liquid above 12, until the cross-section is yellow and uniform, and the tongue feels slightly numb when tasted, take it out, wash it, dry it in the shade or dry it in the oven, and it is ready. French Pinellia tastes spicy and warm in nature. It enters the spleen, stomach, and lung meridians. Efficacy: Drying dampness and resolving phlegm. Indications: Used for dry throat, cough and asthma with excessive phlegm, dizziness and palpitations due to phlegm and fluid, dizziness due to wind and phlegm, and headache due to phlegm. Common dosage: 3 to 15 grams.

[0026] Tangerine peel: It is the ripe peel of the citrus plant and its cultivated varieties of the Rutaceae family. It is warm in nature, pungent and bitter in taste, and enters the spleen meridian, stomach meridian, and lung meridian. Efficacy: Regulating qi and strengthening the spleen, regulating the middle, drying dampness, and resolving phlegm. Indications: Abdominal distension or pain caused by spleen and stomach qi stagnation, and indigestion. Chest tightness and abdominal distension, poor appetite and loose stools caused by dampness and turbidity blocking the middle. Cough and asthma caused by phlegm and dampness blocking the lungs. Used for chest and abdominal distension, poor appetite, vomiting and diarrhea, and cough with a lot of phlegm.

[0027] Ginger: spicy, slightly warm, non-toxic, belongs to the lung, spleen and stomach meridians. It can induce sweating and relieve the symptoms, warm the middle and stop vomiting, warm the lungs and stop coughing, detoxify fish and crabs, and detoxify drugs. It is suitable for exogenous wind-cold, headache, phlegm, cough, stomach cold and vomiting; after being attacked by ice, snow, water, and cold, drink ginger soup immediately to promote blood circulation and dispel cold evil.

[0028] Northern Adenophora: Adenophora is slightly cold in nature and belongs to the lung meridian. It has the effect of nourishing yin and clearing the lungs. It is effective for symptoms such as lung heat and dry cough, fatigue cough with blood in sputum, etc.

[0029] Scutellaria baicalensis: Scutellaria baicalensis is bitter and cold in nature. It enters the lung, gallbladder, spleen, large intestine, and small intestine meridians. It clears away heat and dampness, purges fire and detoxifies, stops bleeding, and stabilizes the fetus. It is used for damp-heat, chest tightness and nausea due to summer heat, damp-heat fullness, diarrhea, jaundice, lung heat cough, high fever and thirst, blood heat vomiting and bleeding, carbuncle, sore, and fetal movement disorder.

[0030] Fritillaria thunbergii: cold in nature, bitter in taste. Enters the lung meridian and heart meridian. Clears away heat and resolves phlegm, dissipates stagnation and detoxifies. Treats wind-heat cough, lung abscess, throat paralysis, scrofula, sores and swelling.

[0031] Sea clam shell: slightly cold in nature, salty in taste. Enters the lung meridian, liver meridian, and stomach meridian. Clears the lungs and resolves phlegm, softens and disperses lumps. Mainly used for cough and asthma caused by lung heat and cough fire, goiter, phlegm nodules, etc.

[0032] Beneficial technical effects of the present invention

[0033] The Chinese medicine composition formula of the present invention is based on the principle of "treating cough from the stomach" and takes harmonizing the stomach and descending adverse as the entry point, and regulates the qi mechanism of the middle jiao to harmonize and descend the stomach qi, and the lung's function of dispersing and descending is normal, and the qi mechanism of the viscera and organs rises and falls, and various evils are eliminated. The Chinese medicine formula of the present invention is guided by the theory of traditional Chinese medicine and clinical research, and is gradually simplified after layers of screening. Pure natural Chinese medicine raw materials are selected, and the whole prescription is prepared in accordance with the principle of "monarch, minister, assistant and messenger" of traditional Chinese medicine. The medicines are compatible, and the rise and fall are caused by each other, and the lung and stomach help each other, and the cough disappears by itself; the monarch medicine in the formula: coptis root and evodia rutaecarpa purge the liver and clear heat, so that the harmonizing and descending function of the stomach returns to normal; the minister medicine in the formula: scutellaria baicalensis, daizheshi, and citrus aurantium are mainly used to descend qi; the adjuvant medicine in the formula: pinellia tuber, dried orange peel, ginger harmonize the stomach; the messenger medicine in the formula: northern adenophora, scutellaria baicalensis, thunbergia thunbergii, and sea clam shell clear heat and relieve cough.

[0034] The Chinese medicine composition formula of the present invention, verified by pharmacodynamic experiments, can effectively inhibit reflux, reduce the occurrence of airway neurogenic inflammation, improve respiratory inflammatory response, and achieve the purpose of treating gastroesophageal reflux cough. Clinical efficacy comparison shows that compared with the Western medicine (omeprazole) treatment group, the treatment group of the present invention is superior to the Western medicine treatment group in improving the cough and belching symptoms of GERC patients, and has a comparable effect on improving the symptoms of acid reflux and heartburn; from the perspective of comprehensive treatment effect, the cure rate of the Chinese medicine of the present invention is 65%, and the total effective rate is 90%, both of which are superior to the Western medicine treatment group (cure rate is 5%, total effective rate is 60%). The clinical effect has been affirmed, no obvious adverse reactions have been observed, and it has significant new drug transformation and application prospects.

[0035] In the traditional Chinese medicine formula of the present invention, the ratio of the traditional Chinese medicine raw materials is obtained through a large number of experimental comparisons and screenings, and has the advantages of good efficacy and significant effects.

[0036] In the traditional Chinese medicine formula of the present invention, the preparation method of the traditional Chinese medicine composition is obtained through a large number of experimental comparisons and screenings, and has the advantages of good efficacy and significant effects.

[0037] In the Chinese medicine composition of the present invention, the fructus aurantii has an excitatory effect on the gastrointestinal smooth muscle, can promote gastric emptying, and thus alleviate the discomfort symptoms caused by reflux. The coptis root and evodia rutaecarpa directly act on the gastric mucosal epithelial cells, thereby inhibiting gastric acid secretion. The Fe2O3 in the daizheshi can reduce bile reflux and restore the acid-base balance in the stomach, and at the same time contains a variety of trace elements, and has a good analgesic effect. DETAILED DESCRIPTION

[0038] The present invention is now described in detail with reference to embodiments, but the implementation of the present invention is not limited thereto.

[0039] The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or under conditions recommended by the manufacturer. The medicinal materials used in the examples of the present invention can be obtained from Chinese medicinal material sales companies unless otherwise specified.

[0040] Example 1: Preparation of the stomach cough, descending qi and stomach-regulating prescription

[0041] Weigh 3 parts of Coptidis Rhizoma, 3 parts of Evodia rutaecarpa, 12 parts of Inulae Radix, 15 parts of Radix Daizheshi, 12 parts of Fructus Aurantii Immaturus, 12 parts of Rhizoma Pinelliae, 6 parts of Pericarpium Citri Reticulatae, 3 parts of Ginger, 15 parts of Adenophora Scutellariae, 15 parts of Bulbus Fritillariae Thunbergii, and 30 parts of Sea Clam Shells.

[0042] Add 8 times the amount of water of the total amount of medicinal materials, heat and boil for half an hour, and pour out the decoction. Add 6 times the amount of water of the total amount of medicinal materials again, heat and boil for half an hour, pour out the decoction, combine the decoctions, filter, and combine the medicinal liquids.

[0043] Example 2: Clinical Observation Effect

[0044] Case source:

[0045] The data were collected from 80 patients with gastroesophageal reflux cough who were admitted to the outpatient clinic and inpatient department of gastroenterology of our hospital from May 2018 to June 2022.

[0046] Inclusion criteria:

[0047] The case selection was in accordance with the Western medicine diagnosis criteria for gastroesophageal reflux disease in the "Chinese Consensus on Gastroesophageal Reflux Disease" and the TCM diagnosis criteria for acid vomiting disease in the "Consensus on TCM Diagnosis and Treatment of Gastroesophageal Reflux Disease"; with choking or cough as the main complaint or symptom; in accordance with the endoscopic diagnosis and classification criteria for reflux esophagitis; aged 18-70 years old, with no special restrictions on gender. Exclusion criteria: 1) combined with other digestive system diseases; 2) combined with other cough-causing diseases; 3) diagnosed with GERD but without cough; 4) severe cardiovascular disease, liver and kidney dysfunction, liver and kidney dysfunction; 5) abdominal surgery, pregnancy, and mental illness. Those with any of the above were excluded.

[0048] Exclusion criteria:

[0049] Those who have taken other gastrointestinal motility machine proton pump inhibitors in the past month; those who suffer from other lung, digestive tract and other systemic diseases; those who have cognitive impairment and cannot cooperate.

[0050] Treatment:

[0051] Treatment group: The decoction of the present invention was administered orally, 1 dose per day, twice a day, morning and evening, for 8 consecutive weeks.

[0052] Control group: Omeprazole capsules (produced by Changzhou Siyao Pharmaceutical Factory) 20 mg were taken orally twice a day.

[0053] The treatment course is 8 weeks. During the medication period, drugs that may affect the observation will be discontinued, and the efficacy will be evaluated after the treatment.

[0054] Observation indicators:

[0055] 1.1 Clinical symptom score

[0056] According to the clinical symptoms of gastroesophageal reflux disease in the 2017 "Expert Consensus on Diagnosis and Treatment of Gastroesophageal Reflux Disease in Traditional Chinese Medicine", and referring to the grading method of relevant symptoms in the "Guidelines for Clinical Research of New Chinese Medicines", the clinical symptom score of this disease was formulated: no symptoms means that such symptoms have never occurred; mild means that they occur occasionally, less than once a day, and do not affect work and rest; moderate means that the frequency of occurrence is between 1 and 3 times a day; severe means that the frequency of occurrence is more than 3 times a day, affecting work and rest. The main complaint of cough is scored from mild to severe according to the above 4 levels, 0, 3, 6, and 9, the main symptoms of gastroesophageal reflux disease (heartburn, belching, acid reflux, chest pain) are scored 0, 2, 4, and 6, and other general symptoms are scored 0, 1, 2, and 3.

[0057] 1.2 Efficacy criteria

[0058] Clinical efficacy criteria: cured: clinical symptoms disappear, symptom score reduced by ≥95%; markedly effective: clinical symptoms basically disappear (although there are occasional symptoms, they disappear quickly), symptom score reduced by 70%-94%; effective: clinical symptoms have not disappeared, but have been alleviated compared with before, symptom score reduced by 30%-69%; ineffective: clinical symptoms have not disappeared, the degree has not been alleviated, and symptom score reduced by <30%. Calculation formula: (pre-treatment score - post-treatment score) / pre-treatment score × 100%.

[0059] Results and analysis:

[0060] 2.1 The scores of the main clinical symptoms of GERC patients in the TCM group and the control group before and after treatment were tested for normality, indicating that they were skewed distribution. The rank sum test showed that there was no significant difference in the scores of the main clinical symptoms before treatment between the two groups: cough, acid reflux, heartburn, and belching (all P>0.05). The scores of the main clinical symptoms in both groups were significantly reduced after treatment compared with those before treatment, and the statistical results of the rank sum test showed significant differences (all P<0.001), indicating that the symptoms of cough, acid reflux, heartburn, and belching in the TCM group and the control group were significantly relieved after treatment.

[0061] The difference in the scores of cough and belching symptoms before and after treatment between the treatment group and the control group was statistically significant (P < 0.05), indicating that the treatment group was superior to the control group in improving the cough and belching symptoms of GERC patients; the difference in the scores of acid reflux and heartburn symptoms before and after treatment between the two groups was not statistically significant (P > 0.05), indicating that the Chinese medicine group and the control group were equally effective in improving acid reflux and heartburn symptoms, as shown in Table 1:

[0062] Table 1 Comparison of main clinical symptom scores of GERC patients (N = 80 cases)

[0063]

[0064] #Compared with the control group, P<0.05

[0065] 2.2 Comparison of total clinical symptom scores

[0066] There was no significant difference in the total scores of clinical symptoms of the two groups of GERC patients before treatment (P = 0.842, > 0.05), indicating that the two groups were comparable before treatment. The total scores of clinical symptoms of the two groups after treatment were statistically significant (P = 0.037, < 0.05), indicating that the treatment group relieved the clinical symptoms of GERC patients significantly better than the control group, as shown in Table 2:

[0067] Table 2 Comparison of total clinical symptom scores of patients with gastroesophageal reflux cough in the Chinese medicine group and the control group

[0068]

[0069] #Compared with the control group, P<0.05

[0070] 2.3 Comparison of clinical total effective rate

[0071] After treatment, 26 cases (65%) of the Chinese medicine group were cured, 5 cases were markedly effective, 5 cases were effective, 4 cases were ineffective, and the total effective rate was 90%; 2 cases (5%) of the control group were cured, 6 cases were markedly effective, 16 cases were effective, 4 cases were ineffective, and the total effective rate was 60%. Compared with the control group, the total effective rate of the Chinese medicine group was significantly higher than that of the control group (P<0.05), indicating that the Chinese medicine composition of the present invention has a good therapeutic effect on the treatment of GERC, as shown in Table 3:

[0072] Table 3 Comparison of overall clinical efficacy of gastroesophageal reflux cough in the Chinese medicine group and the control group (cases)

[0073]

[0074] Example 3: Animal experiment of the present invention

[0075] 1. Experimental Materials

[0076] Experimental animals and feeding conditions

[0077] Experimental animals: 60 ordinary guinea pigs, 2-4 months old, body weight (300±50g), were randomly divided into a control group (taking omeprazole) and the rest as experimental groups with 15 animals in each group using a random number table. Animal source: Shanghai Slake Experimental Animal Co., Ltd.; license number: SCXK (Shanghai) 2012-0002; breeding conditions: constant temperature: (25±0.5), relative humidity: (55±5)%, constant light, and clean conditions. They were raised in the animal room of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine.

[0078] 2. Experimental methods

[0079] 2.1 Modeling and drug administration methods

[0080] Normal group: The mice were given free drinking water and intragastric administration for 14 days.

[0081] Model group: The GERC animal model was established by hydrochloric acid perfusion method (reference: Liu Chunli, Lai Fang, Chen Ruchong, et al. Establishment of esophageal reflux disease model in guinea pigs by hydrochloric acid perfusion [J]. Chinese Journal of Pathophysiology, 2006, 22(3): 620-621.), and the animals were given free drinking water for 14 consecutive days.

[0082] Chinese medicine group: The dosage was based on the total daily clinical dosage, and the equivalent dosage for humans and animals was converted according to the body surface area. The body weight of the test animals was recorded during the administration period, and the dosage was increased as the body weight changed. Each time, 1 mL / 100 g body weight was administered by intragastric gavage for 14 consecutive days.

[0083] Western medicine group: The control group was given omeprazole 0.367 mg / 100 g, twice a day by gavage, 1 mL / 100 g body weight each time, for 14 consecutive days.

[0084] 2.2 Specimen collection and processing

[0085] Preparation of light microscopic pathological sections of trachea and lung tissue: Guinea pigs were killed by intraperitoneal overdose injection of 2% sodium pentobarbital, and 0.5 cm tissue near the larynx and 1 cm × 1 cm lung tissue were removed, fixed in 10% formaldehyde solution, dehydrated, embedded in paraffin, sliced, stained with hematoxylin-eosin, and sealed with resin. The morphological manifestations of trachea and lung tissue were observed under a light microscope. The tracheal inflammation pathological score was evaluated by referring to the eight pathological index scoring standards of the small airways formulated in the prior art, and the lung tissue inflammation score was evaluated according to the severity of eosinophils around blood vessels and trachea, epithelial damage, and edema.

[0086] Preparation of lung tissue electron microscopic pathological sections: quickly remove 0.5cm×0.5cm of lung tissue at low temperature, fix it with 2% glutaraldehyde fixative for more than 2h in a low temperature environment, and wash it thoroughly with 0.1mol / L phosphate buffer; post-fix it with 1% osmium acid for 2h, and wash it with phosphate buffer for 0.5h; dehydrate it with gradient alcohol; embed it with epoxy resin; make ultrathin sections (80nm); observe the morphology of microvascular endothelial cells, basement membrane morphology, and capillary wall electron density of lung tissue under a transmission electron microscope.

[0087] 3. Experimental results

[0088] 3.1 Tracheal inflammatory changes

[0089] The results are shown in Table 4 below. Compared with the normal group, inflammatory cell infiltration occurred in the tracheal tissue of the model group (P>0.05). Compared with the model group, the inflammatory cell infiltration in the Chinese medicine group and the control group was reduced compared with the model group (P<0.05). Compared with the control group, the tracheal inflammation score in the Chinese medicine group was lower than that in the control group, and the difference between the two was statistically significant (P<0.05).

[0090] Table 4 Comparison of tracheal pathological scores of guinea pigs in each group (score, x±s)

[0091]

[0092] *Compared with the normal group, P<0.05; #Compared with the Chinese medicine group, P<0.05

[0093] 3.2 Tracheal pathological changes

[0094] The results are shown in Table 5 below. Compared with the normal group, the lung tissue inflammation score in the model group was increased, and the difference was statistically significant (P<0.05); compared with the model group, the lung tissue inflammation score in the Chinese medicine group and the Western medicine group was decreased, and the difference was statistically significant (P<0.05); compared with the Western medicine group, the lung tissue inflammation score in the Chinese medicine group was decreased, and the difference was statistically significant (P<0.05).

[0095] Table 5 Comparison of lung tissue pathological scores in each group (score, x±s)

[0096]

[0097] *Compared with the normal group, P<0.05; #Compared with the Chinese medicine group, P<0.05

[0098] In summary, in the animal experiment of this embodiment, the damage of reflux fluid to the guinea pig airway is mainly manifested in the proliferation of ciliated columnar epithelium and the infiltration of inflammatory cells, and the damage of lung tissue is mainly manifested in the damage of capillary-alveolar membrane, destruction of alveolar structure and infiltration of inflammatory cells. At the same time, the interstitial edema and inflammatory cell infiltration of lung tissue in each experimental group were significantly milder than those in the control group, and the capillary-alveolar membrane was not significantly damaged. This suggests that the Chinese medicine group prepared by using Chinese medicine extracts can reduce the repeated stimulation of reflux to the lower end of the esophagus, reduce the occurrence of airway neurogenic inflammation, and thus play a role in treating GERC.

[0099] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. The present invention may be subject to various changes and improvements without departing from the spirit and scope of the present invention. These changes and improvements fall within the scope of the present invention. The scope of protection of the present invention is defined by the attached claims and their equivalents.

Claims

1. A Chinese medicine composition for treating gastroesophageal reflux cough, It is characterized in that The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 3-6 parts of coptis root, 3-6 parts of evodia rutaecarpa, 10-20 parts of inula stem, 15-25 parts of magnetite, 10-20 parts of fructus aurantii, 10-20 parts of pinellia tuber, 5-10 parts of dried tangerine peel, 3-6 parts of ginger, 10-20 parts of adenophora adenophora, 10-20 parts of scutellaria baicalensis, 10-20 parts of fritillaria thunbergii and 20-30 parts of sea clam shell.

2. The Chinese medicine composition for treating gastroesophageal reflux cough according to claim 1, It is characterized in that The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 3 parts of coptis root, 3 parts of evodia rutaecarpa, 12 parts of inula stem, 15 parts of magnetite, 12 parts of fructus aurantii, 12 parts of pinellia tuber, 6 parts of tangerine peel, 3 parts of ginger, 15 parts of adenophora adenophora, 15 parts of scutellaria baicalensis, 12 parts of fritillaria thunbergii and 30 parts of sea clam shell.

3. The Chinese medicine composition for treating gastroesophageal reflux cough according to claim 1 or 2, It is characterized in that In the traditional Chinese medicine composition, coptis root and evodia rutaecarpa are the main drugs, inula stem, magnetite and aurantium are the assistant drugs, pinellia tuber, tangerine peel and ginger are the adjuvant drugs, and adenophora adenophora, scutellaria baicalensis, fritillaria thunbergii and sea clam shell are the guiding drugs.

4. Use of the Chinese medicine composition for treating gastroesophageal reflux cough according to claim 1 or 2 in the preparation of a pharmaceutical preparation for treating or alleviating gastroesophageal reflux cough.

5. A pharmaceutical preparation for treating gastroesophageal reflux cough, It is characterized in that The Chinese medicine composition for treating gastroesophageal reflux cough according to claim 1 or 2 is used as an active ingredient.

6. The pharmaceutical preparation for treating gastroesophageal reflux cough according to claim 5, It is characterized in that The preparation method is as follows: take the raw materials according to the weight portion, mix them according to the proportion, add 8 times the total amount of water of the medicinal materials, heat and boil for half an hour, and pour out the decoction; add 6 times the total amount of water of the medicinal materials again, heat and boil for half an hour, pour out the decoction, combine the decoctions, filter, and combine the medicinal liquids.

7. The pharmaceutical preparation for treating gastroesophageal reflux cough according to claim 5, It is characterized in that The pharmaceutical preparation is used in combination with other therapeutic agents.

8. The pharmaceutical preparation for treating gastroesophageal reflux cough according to claim 7, It is characterized in that The additional therapeutic agent is selected from a proton pump inhibitor or vonoprazan.

Citation Information

Patent Citations

  • Traditional Chinese medicine composition for treating gastroesophageal reflux cough and application thereof

    CN116115726A